jim_asheville said:

Insurance update relevant to cost and coverage: I just got my prior auth approved through Cigna after 3 attempts.

jim_asheville said:

...regarding the discontinuation data for cost and coverage...

I want to reframe the discontinuation narrative. We don't say "insulin fails because blood sugar rises when you stop it." We don't say "antihypertensives fail because BP goes up without them."

Why do we apply different logic to anti-obesity medications? The answer is stigma. We still, unconsciously, believe obesity is about willpower rather than biology. The discontinuation data actually PROVES it's a chronic biological condition requiring ongoing treatment.

This reframing isn't semantic — it has implications for insurance coverage, treatment duration, and patient expectations.

carlos_SATX said:

TrialNerd_Beth said: ...compounded vs brand cost and coverage...

This is exactly what I could not find anywhere else. Printing the relevant bit and taking it with me.

jim_asheville said:

Insurance update relevant to cost and coverage: I just got my prior auth approved through Cigna after 3 attempts.

My insurance denied my PA related to cost and coverage. Has anyone successfully appealed? I'm considering going compounded instead.

NeuroNate said:

Denied on prior authorisation twice, approved on the third attempt after a peer-to-peer, and the only thing that changed was who was doing the…

Financial impact of cost and coverage weight loss beyond medication cost:

• Groceries: SAVED $229/month (eating less)
• Restaurants: SAVED $199/month (fewer meals out)
• Alcohol: SAVED $149/month (stopped drinking)
• Life insurance: Premium REDUCED by $39/month (lower BMI)
• Copays: SAVED $69/month (fewer BP/cholesterol meds)

Net impact after medication cost: approximately BREAKING EVEN. The medication pays for itself through reduced food spending and healthcare costs. This surprised me.

Moderator note: reminder that nothing in this thread is medical advice, and that clinical claims need a source. Carry on.